Professor Carolyn Mountford

M.Sc. Biophysics, D.Phil. Biochemistry & Biophysics, M.S. Radiology

CEO and Director of Research, TRI

About me

Professor Mountford and her team are currently working to improve MR spectroscopy technology and broaden its medical application. This work has already resulted in techniques used by research centres and hospitals for patients with cancer, brain tumours, and neurologic and psychological disorders. 

The USA and Australian military have contracted her team to further develop the new MR in vivo approach that diagnoses changes to brain chemistry associated with brain injury and post traumatic stress disorder. These in turn promise new therapeutic approaches.

One of Prof Mountford’s programs has developed a way to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumor growth. 

Professor Mountford comes to TRI from the University of Newcastle where she was the Professor of Radiology and Director of the Centre for MR in Health since 2011. Other roles include full Professor of Radiology at Harvard Medical School since 2007, and Director of the Centre for Clinical Spectroscopy at the Brigham and Women’s Hospital in Boston since 2006.  

 

Awards and Milestones

Author or co-author of more than 180 peer-reviewed articles

The recipient of:

  • The Graham Coupland Medal from the Royal Australasian College of Surgeons
  • Inaugural Pioneer of Hope Award from the NSW Cancer Council
  • Fellow, Society of Magnetic Resonance in Medicine
  • Innovation Flagship Award from the Federal and NSW governments
  • Awarded NHMRC Clinical Centre of Excellence in the first round
  • US & Australian Departments of Defense solicited contracts as well as NIH, NHMRC and ARC grants
  • Agilent Thought Leader Award
  • WW Development site for Siemens Healthcare for over 15 years

Projects

Current Funded Projects

  • 2010-14 Identifying biomarkers that distinguish post-traumatic stress disorder and mild traumatic brain injury using advanced magnetic resonance spectroscopy.DoD CDMRP Investigator Research Award (PT090609).Co-I ($1,157,943).
  • 2013-16 Spectroscopy at 3T $Commercial in confidenceRole: PI
  • 2011- 2014 Chronic Traumatic Encephalopathy: Clinical Presentation and BiomarkersNational Institutes of Health and National Institute of Aging Grant ID R01AG038758-01 $2,241,000.
  • 2010- 2013 Identifying biomarkers that distinguish post-traumatic stress disorder and mild traumatic brain injury using advanced magnetic resonanceDepartment of Defense Congressionally Directed Medical Research Programs DoDCDMRP (W81XWH-10-1-0835) ($1,157,943)Role: Co-investigator.
  • 2012-2013 Pilot study to identify none invasively a pre-invasive change to the breast in high risk women. HCRA ($20K)
  • 2012-2013 Pilot study to develop technology to monitor the effect of neoadjuvent therapy prior to surgery. HCRA ($20K).
  • 2012 Establishment of MR pathology Laboratory HCRA ($43K).
  • 2013 – 2014 Establishment of MR pathology Laboratory Agilent Technologies ($500K)Role: PI.
  • 2013- 2015 Biomarkers for Mild Traumatic Brain Injury, Blast Injury and Post Traumatic Stress Disorder. USA and Australian DoD, Agreement 498030 ($1.05M)Role: PI.
  • 2014-2015 New MR Technology Identifies Biomarkers in Individuals